tiprankstipranks
Gland Pharma Ltd. (IN:GLAND)
:GLAND
India Market
GLAND
Gland Pharma Ltd.
RESEARCH TOOLSreports
Want to see IN:GLAND full AI Analyst Report?

Gland Pharma Ltd. (GLAND) Financial Statements

1 Followers

Gland Pharma Ltd. Financial Overview

Gland Pharma Ltd.'s market cap is currently ₹365.86B. The company's EPS TTM is ₹47.97; its P/E ratio is 27.20; and it has a dividend yield of 1.07%. Gland Pharma Ltd. is scheduled to report earnings on May 15, 2026, and the estimated EPS forecast is ₹17.00. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue₹ 64.31B₹ 56.17B₹ 56.65B₹ 36.25B₹ 44.01B
Gross Profit₹ 19.32B₹ 31.54B₹ 31.11B₹ 17.65B₹ 21.51B
Operating Income₹ 12.06B₹ 17.38B₹ 18.23B₹ 11.57B₹ 15.84B
EBITDA₹ 16.30B₹ 12.31B₹ 12.97B₹ 10.31B₹ 15.10B
Net Income₹ 10.27B₹ 6.99B₹ 7.72B₹ 7.81B₹ 12.12B
Balance Sheet
Cash & Short-Term Investments₹ 33.59B₹ 29.52B₹ 19.39B₹ 37.63B₹ 32.43B
Total Assets₹ 125.11B₹ 112.25B₹ 106.61B₹ 87.78B₹ 78.34B
Total Debt₹ 2.84B₹ 3.14B₹ 3.72B₹ 44.53M₹ 47.43M
Net Debt₹ -30.76B₹ -22.42B₹ 150.78M₹ -19.04B₹ -3.11B
Total Liabilities₹ 21.53B₹ 20.74B₹ 19.37B₹ 8.19B₹ 6.76B
Stockholders' Equity₹ 103.58B₹ 91.51B₹ 87.24B₹ 79.59B₹ 71.58B
Cash Flow
Free Cash Flow₹ 7.41B₹ 5.30B₹ 6.07B₹ 1.41B₹ 2.69B
Operating Cash Flow₹ 12.31B₹ 9.15B₹ 9.97B₹ 3.64B₹ 7.91B
Investing Cash Flow₹ -945.34M₹ 17.05B₹ -17.57B₹ 12.08B₹ -10.03B
Financing Cash Flow₹ -3.85B₹ -4.33B₹ -7.99B₹ 149.19M₹ 348.98M
Currency in INR

Gland Pharma Ltd. Earnings and Revenue History

Income Statement >

Gland Pharma Ltd. Debt to Assets

Balance Sheet >

Gland Pharma Ltd. Cash Flow

Cash Flow >

Gland Pharma Ltd. Forecast EPS vs Actual EPS

Earnings >